Plain-English translation of NCT03703271 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is comparing two different first treatments for a type of placental tumor called low-risk gestational trophoblastic neoplasia. One group will receive a procedure called hysteroscopic repeat curettage (a gentle cleaning of the uterus), while the other group will receive , a chemotherapy medication that has been the standard treatment for many years. The study wants to see if the uterine cleaning procedure works just as well while causing fewer side effects and improving quality of life.
Standard chemotherapy for this condition can cause serious side effects like nausea, low blood counts, and liver problems, and treatment takes a long time. Recent research suggests that for some patients at very low risk, a simpler procedure might work just as well without these harsh side effects.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to either receive the uterine cleaning procedure or to start chemotherapy treatment with . The chemotherapy group would receive injections over 5 days at the start of each cycle, with cycles repeated every two weeks. Both groups will have regular blood tests and monitoring of tumor markers to track how well the treatment is working. Your doctors will follow your progress closely to ensure the treatment is effective and to manage any side effects.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China